Astellas Pharma Korea, Inc.
Clinical trials sponsored by Astellas Pharma Korea, Inc., explained in plain language.
-
New drug VYLOY under Real-World watch for stomach cancer safety
Disease control Recruiting nowThis study monitors the safety of the drug VYLOY in 377 people in South Korea with advanced stomach or gastroesophageal junction cancer that cannot be removed by surgery or has spread. Participants receive VYLOY as part of their normal care, and researchers track side effects and…
Sponsor: Astellas Pharma Korea, Inc. • Aim: Disease control
Last updated May 26, 2026 08:20 UTC
-
South korea launches real-world safety check on bladder cancer drug PADCEV
Knowledge-focused Recruiting nowThis study is observing about 200 adults in South Korea with advanced bladder cancer who are already prescribed PADCEV. Researchers will track side effects and how well the cancer responds over about one year. No new treatments are given—only medical records are reviewed.
Sponsor: Astellas Pharma Korea, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 08:33 UTC